Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 3
Submit an article Journal homepage
2,620
Views
86
CrossRef citations to date
0
Altmetric
Original Research

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Oana DraghiciuDepartment of Medical Microbiology, Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen; Groningen, the Netherlands
,
Hans W NijmanDepartment of Gynecology; University of Groningen; University Medical Center Groningen; Groningen, the Netherlands
,
Baukje Nynke HoogeboomDepartment of Medical Microbiology, Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen; Groningen, the Netherlands
,
Tjarko MeijerhofDepartment of Medical Microbiology, Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen; Groningen, the Netherlands
&
Toos DaemenDepartment of Medical Microbiology, Tumor Virology and Cancer Immunotherapy; University of Groningen; University Medical Center Groningen; Groningen, the NetherlandsCorrespondence[email protected]
Article: e989764 | Received 08 Oct 2014, Accepted 14 Nov 2014, Published online: 02 Apr 2015

Citations (86)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Alice Mougel, Fanny Méjean, Thi Tran, Yasmine Adimi, Isabelle Galy-Fauroux, Christelle Kaboré, Erwan Mercier, Pauline Urquia, Magali Terme, Eric Tartour & Corinne Tanchot. (2022) Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling. OncoImmunology 11:1.
Read now
Zhongmin Li, Yilun Liu, Xuedong Fang & Zhenbo Shu. (2021) Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy. International Journal of Nanomedicine 16, pages 1631-1661.
Read now
Viktoria Stühler, Steffen Rausch, Jan Moritz Maas, Arnulf Stenzl & Jens Bedke. (2021) Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma. Expert Opinion on Biological Therapy 21:9, pages 1215-1226.
Read now
Viktoria Stühler, Steffen Rausch, Arnulf Stenzl & Jens Bedke. (2021) Genetic analysis of primary renal cell carcinoma to determine treatment approaches. Expert Review of Precision Medicine and Drug Development 6:2, pages 107-115.
Read now
Xiaojie Chu, Yang Li, Weiwei Huang, Xuejun Feng, Pengyan Sun, Yufeng Yao, Xu Yang, Wenjia Sun, Hongmei Bai, Cunbao Liu & Yanbing Ma. (2018) Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1199-1209.
Read now
Dai Liu, Guangfu Li, Diego M. Avella, Eric T. Kimchi, Jussuf T. Kaifi, Mark P. Rubinstein, E. Ramsay Camp, Don C. Rockey, Todd D. Schell & Kevin F. Staveley-O'Carroll. (2018) Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer. OncoImmunology 7:1.
Read now
Jinjing Xu, Kang Tian, Haixu Zhang, Liantao Li, Hongyan Liu, Jingjie Liu, Qing Zhang & Junnian Zheng. (2017) Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens. Expert Review of Anticancer Therapy 17:12, pages 1099-1106.
Read now
Zibing Wang, Brian Till & Quanli Gao. (2017) Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells. OncoImmunology 6:7.
Read now
Zhonglin Hao & Ibrahim Sadek. (2016) Sunitinib: the antiangiogenic effects and beyond. OncoTargets and Therapy 9, pages 5495-5505.
Read now
Oana Draghiciu, Annemarie Boerma, Baukje Nynke Hoogeboom, Hans W Nijman & Toos Daemen. (2015) A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development. OncoImmunology 4:10.
Read now

Articles from other publishers (76)

Inès Dufait, Els Van Valckenborgh, Eline Menu, David Escors, Mark De Ridder & Karine Breckpot. (2016) Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy. Oncotarget 7:27, pages 42698-42715.
Crossref
Prashant Sharma & Mario Otto. (2024) Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy. Bioactive Materials 31, pages 440-462.
Crossref
Jhon Jairo Calderon, Karol Prieto, Paola Lasso, Susana Fiorentino & Alfonso Barreto. (2023) Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products. Archivum Immunologiae et Therapiae Experimentalis 71:1.
Crossref
Ling-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, Pei-Yi Chu, Tzu-Ting Huang, Chia-Han Lee, Wan-Lun Wang, Yuan-Ya Chang, Chun-Teng Huang, Chi-Cheng Huang, Ta-Chung Chao, Yi-Fang Tsai, Jiun-I Lai, Ming-Shen Dai & Chun-Yu Liu. (2023) Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model. Experimental Cell Research 429:1, pages 113652.
Crossref
Ruiyang Ren, Chenyi Xiong, Runyu Ma, Yixuan Wang, Tianyang Yue, Jiayun Yu & Bin Shao. (2023) The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers. MedComm 4:4.
Crossref
Smita Kumari, Rohan Gupta, Rashmi K. Ambasta & Pravir Kumar. (2023) Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188913.
Crossref
Suzanne Ostrand-Rosenberg, Tracey J. Lamb & Graham Pawelec. (2023) Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology. The Journal of Immunology 210:9, pages 1183-1197.
Crossref
Xinjun Liu, Jian Zhao, Xiaopeng Li, Fengxue Lao & Min Fang. (2022) Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy. Vaccines 10:9, pages 1552.
Crossref
Chiel van Geffen, Constantin Heiss, Astrid Deißler & Saeed Kolahian. (2022) Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation. Frontiers in Immunology 13.
Crossref
Mimma Rizzo, Luca Varnier, Gaetano Pezzicoli, Marta Pirovano, Laura Cosmai & Camillo Porta. (2022) IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma. Frontiers in Oncology 12.
Crossref
Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Pablo Maroto Rey, Henryk Zieliński, Felipe Villacampa, Pierre Bigot, Bajory Zoltan, Omi Parikh, David Vazquez Alba, Åsa Jellvert, Tibor Flaskó, Enrique Gallardo, Maria José Ribal Caparrós, Gunta Purkalne, Peter Suenaert, Alex Karlsson-Parra & Börje Ljungberg. (2022) Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study. European Urology Open Science 40, pages 38-45.
Crossref
Mohammad Taleb, Niloufar Mohammadkhani, Farbod Bahreini, Muhammad Ovais & Guangjun Nie. (2022) Modulation of Tumor Vasculature Network: Key Strategies. Small Structures 3:6.
Crossref
Yuqing Zhang & Rolf A Brekken. (2022) Direct and indirect regulation of the tumor immune microenvironment by VEGF. Journal of Leukocyte Biology 111:6, pages 1269-1286.
Crossref
Filippos Koinis, Anastasia Xagara, Evangelia Chantzara, Vassiliki Leontopoulou, Chrissovalantis Aidarinis & Athanasios Kotsakis. (2021) Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives. Cells 11:1, pages 20.
Crossref
Chunying Peng, Katrin Rabold, Willem J. M. Mulder, Martin Jaeger & Romana T. Netea-Maier. (2021) Kinase Inhibitors’ Effects on Innate Immunity in Solid Cancers. Cancers 13:22, pages 5695.
Crossref
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil & Homa Darmani. (2021) Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection. Open Biology 11:11.
Crossref
Kai Li, Houhui Shi, Benxia Zhang, Xuejin Ou, Qizhi Ma, Yue Chen, Pei Shu, Dan Li & Yongsheng Wang. (2021) Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduction and Targeted Therapy 6:1.
Crossref
Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan & Albert D M E Osterhaus. (2021) Influenza Vaccines: Successes and Continuing Challenges. The Journal of Infectious Diseases 224:Supplement_4, pages S405-S419.
Crossref
Xinghang Dai, Long Ren, Mengxi Liu, Hao Cai, Hu Zhang, Qiyong Gong, Zhongwei Gu & Kui Luo. (2021) Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy. Nano Today 39, pages 101163.
Crossref
Sijia Ren, Xinxin Xiong, Hua You, Jianfei Shen & Penghui Zhou. (2021) The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer. Frontiers in Immunology 12.
Crossref
Jessica K. Mandula & Paulo C. Rodriguez. (2021) Tumor-related stress regulates functional plasticity of MDSCs. Cellular Immunology 363, pages 104312.
Crossref
Latika Singh, Eric S. Muise, Anannya Bhattacharya, Jeff Grein, Sarah Javaid, Peter Stivers, Jun Zhang, Yujie Qu, Barbara Joyce-Shaikh, Andrey Loboda, Chunsheng Zhang, Michael Meehl, Derek Y. Chiang, Sheila H. Ranganath, Michael Rosenzweig & Philip E. Brandish. (2021) ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells. Molecular Cancer Research 19:4, pages 702-716.
Crossref
Jun-Yan Li, Yu-Pei Chen, Ying-Qin Li, Na Liu & Jun Ma. (2021) Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades. Molecular Cancer 20:1.
Crossref
Patrick Greve, Friederike A G Meyer-Wentrup, Victor Peperzak & Marianne Boes. (2021) Upcoming immunotherapeutic combinations for B-cell lymphoma. Immunotherapy Advances 1:1.
Crossref
Hoyoung M. Maeng & Jay A. Berzofsky. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine 307 328 .
Xiaoyin Wang, Chen Liang, Wenjiao Xia, Changjiang Guo, Zhiyuan Niu, Wuling Zhu & Huiyong Zhang. (2020) VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway. Molecular Immunology 128, pages 41-46.
Crossref
Ilaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo, Andrea Botticelli, Alain Gelibter, Fabio Calabrò, Ernesto Rossi, Giovanni Schinzari, Federica Urbano, Giulia Pomati, Simone Scagnoli, Aurelia Rughetti, Salvatore Caponnetto, Paolo Marchetti & Marianna Nuti. (2020) Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma. Cancers 12:9, pages 2620.
Crossref
Xian Liang Duan, Jian Ping Guo, Fan Li, Chao XiuHua Wang. (2020) Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice. Future Oncology 16:24, pages 1815-1824.
Crossref
Laure Hirsch, Ronan Flippot, Bernard Escudier & Laurence Albiges. (2020) Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma. Drugs 80:12, pages 1169-1181.
Crossref
Bo Sun, Hyesun Hyun, Lian-tao Li & Andrew Z Wang. (2020) Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment. Acta Pharmacologica Sinica 41:7, pages 970-985.
Crossref
Huiyong Zhang, Wenjiao Xia, Chen Liang, Xiaoyin Wang, Lingtong Zhi, Changjiang Guo, Zhiyuan Niu & Wuling Zhu. (2020) VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice. Molecular Immunology 122, pages 132-140.
Crossref
Kalliopi Domvri, Savvas Petanidis, Doxakis Anestakis, Konstantinos Porpodis, Chong Bai, Paul Zarogoulidis, Lutz Freitag, Wolfgang Hohenforst-Schmidt & Theodora Katopodi. (2020) Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment. Nanoscale 12:13, pages 7051-7062.
Crossref
Hongda Zhu, Qi Liu, Lei Miao, Sara Musetti, Meirong Huo & Leaf Huang. (2020) Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy. Nanoscale 12:5, pages 3400-3410.
Crossref
Jihyun Lim, Aram Lee, Hee Gu Lee & Jong-Seok Lim. (2020) Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells. Biomolecules & Therapeutics 28:1, pages 1-17.
Crossref
Huizhong Li, Jiage Ding, Mengmeng Lu, Hongyan Liu, Yangna Miao, Liantao Li, Gang Wang, Junnian Zheng, Dongsheng Pei & Qing Zhang. (2020) CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models. Journal of Immunotherapy 43:1, pages 16-28.
Crossref
Takumi Kishimoto, Nobukazu Fujimoto, Takeshi Ebara, Toyonori Omori, Tetsuya Oguri, Akio Niimi, Takako Yokoyama, Munehiro Kato, Ikuji Usami, Masayuki Nishio, Kosho Yoshikawa, Takeshi Tokuyama, Mouka Tamura, Yoshifumi Yokoyama, Ken Tsuboi, Yoichi Matsuo, Jiegou Xu, Satoru Takahashi, Mohamed Abdelgied, William T. Alexander, David B. Alexander & Hiroyuki Tsuda. (2019) Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients. BMC Cancer 19:1.
Crossref
Lisa Haas & Anna C. Obenauf. (2019) Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment. Frontiers in Immunology 10.
Crossref
Elaine Reguera-Nuñez, Shan Man, Ping Xu, Frank Hilberg & Robert S. Kerbel. (2019) Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity. Angiogenesis 22:4, pages 535-546.
Crossref
Pacôme Lecot, Matthieu Sarabi, Manuela Pereira Abrantes, Julie Mussard, Leo Koenderman, Christophe Caux, Nathalie Bendriss-Vermare & Marie-Cécile Michallet. (2019) Neutrophil Heterogeneity in Cancer: From Biology to Therapies. Frontiers in Immunology 10.
Crossref
Kathleen Puttmann, Megan Duggan, Amir Mortazavi, Dayssy Alexandra Diaz, William E. Carson III & Debasish Sundi. (2019) The Role of Myeloid Derived Suppressor Cells in Urothelial Carcinoma Immunotherapy. Bladder Cancer 5:2, pages 103-114.
Crossref
Andy S. Ding, Denis Routkevitch, Christina Jackson & Michael Lim. (2019) Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors. Frontiers in Immunology 10.
Crossref
Bas D. Koster, Saskia J. A. M. Santegoets, Jorien Harting, Arnold Baars, S. Marieke van Ham, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl & Alfons J. M. van den Eertwegh. (2019) Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer Immunology, Immunotherapy 68:6, pages 1025-1035.
Crossref
Amrita Singh, Georgia Koutsoumpli, Stephanie van de Wall & Toos Daemen. (2018) An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunology, Immunotherapy 68:5, pages 849-859.
Crossref
Hyunjoon Kim, Vidhi Khanna, Tamara A. Kucaba, Wenqiu Zhang, David M. Ferguson, Thomas S. Griffith & Jayanth Panyam. (2019) Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine. Molecular Pharmaceutics 16:3, pages 1200-1210.
Crossref
Jie Zheng & Peng Gao. (2019) Toward Normalization of the Tumor Microenvironment for Cancer Therapy. Integrative Cancer Therapies 18, pages 153473541986235.
Crossref
Laurene S. Cheung, Geetha Srikrishna & William R. Bishai. 2019. Tuberculosis Host-Pathogen Interactions. Tuberculosis Host-Pathogen Interactions 63 93 .
Hor-Yue Tan, Ning Wang, Wing Lam, Wei Guo, Yibin Feng & Yung-Chi Cheng. (2018) Targeting tumour microenvironment by tyrosine kinase inhibitor. Molecular Cancer 17:1.
Crossref
Xinfeng Chen, Liping Wang, Pupu Li, Mengjia Song, Guohui Qin, Qun Gao, Zhen Zhang, Dongli Yue, Dan Wang, Shufeng Nan, Yu Qi, Feng Li, Li Yang, Lan Huang, Mingzhi Zhang, Bin Zhang, Yanfeng Gao & Yi Zhang. (2018) Dual TGF‐β and PD‐1 blockade synergistically enhances MAGE‐A3‐specific CD8 + T cell response in esophageal squamous cell carcinoma . International Journal of Cancer 143:10, pages 2561-2574.
Crossref
M. Nuti, I.G. Zizzari, A. Botticelli, A. Rughetti & P. Marchetti. (2018) The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one. Cancer Treatment Reviews 70, pages 41-46.
Crossref
Nelita du Plessis, Leigh A. Kotze, Vinzeigh Leukes & Gerhard Walzl. (2018) Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Alex Karlsson-Parra, Juliana Kovacka, Emilia Heimann, Margareth Jorvid, Sijme Zeilemaker, Sharon Longhurst & Peter Suenaert. (2018) Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. Pharmaceutical Research 35:8.
Crossref
Ilaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli, Salvatore Caponnetto, Fabio Calabrò, Alain Gelibter, Aurelia Rughetti, Ilary Ruscito, Hassan Rahimi, Ernesto Rossi, Giovanni Schinzari, Paolo Marchetti & Marianna Nuti. (2018) TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway. Cancer Immunology Research 6:6, pages 711-722.
Crossref
David F. McDermott, Mahrukh A. Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini, Bernard Escudier, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, James A. Reeves, Mario Sznol, John Hainsworth, W. Kimryn Rathmell, Walter M. Stadler, Thomas Hutson, Martin E. Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K. Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault-Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S. Chen, Priti S. Hegde, Christina Schiff, Gregg D. Fine & Thomas Powles. (2018) Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nature Medicine 24:6, pages 749-757.
Crossref
Ju Yang, Jing Yan & Baorui Liu. (2018) Targeting VEGF/VEGFR to Modulate Antitumor Immunity. Frontiers in Immunology 9.
Crossref
Nizar M. Tannir, Sumanta K. Pal & Michael B. Atkins. (2018) Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review. The Oncologist 23:5, pages 540-555.
Crossref
Minah Kim, Maximilian Nitschké, Barbara Sennino, Patrizia Murer, Brian J. Schriver, Alexander Bell, Aishwarya Subramanian, Corry E. McDonald, Jiahu Wang, Howard Cha, Marie-Claude Bourgeois-Daigneault, David H. Kirn, John C. Bell, Naomi De Silva, Caroline J. Breitbach & Donald M. McDonald. (2018) Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms. Cancer Research 78:4, pages 922-937.
Crossref
Margot Zöller. (2018) Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease. Frontiers in Immunology 9.
Crossref
Andrew J. Bryant, Vinayak Shenoy, Chunhua Fu, George Marek, Kyle J. Lorentsen, Erica L. Herzog, Mark L. Brantly, Dorina Avram & Edward W. Scott. (2018) Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology 58:2, pages 170-180.
Crossref
Eric Tartour. (2019) Vaccins anti-cancer : quel avenir dans les stratégies d’immunothérapie anti-cancéreuse ?. Biologie Aujourd'hui 212:3-4, pages 69-76.
Crossref
Chunyan Li, Tao Liu, Alexandr V. Bazhin & Yuhui Yang. (2017) The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia. Journal of Cellular Physiology 232:9, pages 2312-2322.
Crossref
Andrew W Hahn, David M Gill, Sumanta K Pal & Neeraj Agarwal. (2017) The future of immune checkpoint cancer therapy after PD-1 and CTLA-4. Immunotherapy 9:8, pages 681-692.
Crossref
Andrew J. Garton, Scott Seibel, Lori Lopresti-Morrow, Linda Crew, Neal Janson, Sreekala Mandiyan, E. Sergio Trombetta, Shannon Pankratz, Theresa M. LaVallee & Richard Gedrich. (2017) Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression. Molecular Cancer Therapeutics 16:4, pages 671-680.
Crossref
Chenxi Hu & Xiaodong Jiang. (2017) The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment. Biomedicine & Pharmacotherapy 88, pages 134-137.
Crossref
N. Achini Bandara, Cody D. Bates, Yingjuan Lu, Emily K. Hoylman & Philip S. Low. (2017) Folate-Hapten–Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer. Molecular Cancer Therapeutics 16:3, pages 461-468.
Crossref
Meirong Huo, Yan Zhao, Andrew Benson Satterlee, Yuhua Wang, Ying Xu & Leaf Huang. (2017) Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. Journal of Controlled Release 245, pages 81-94.
Crossref
M.L. Capitano, S. Zhang & H.E. Broxmeyer. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Tessa Gargett, Susan N Christo, Timothy R Hercus, Nazim Abbas, Nimit Singhal, Angel F Lopez & Michael P Brown. (2016) GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro. Clinical & Translational Immunology 5:12, pages e119.
Crossref
Lakshmi Jayashankar & Richard Hafner. (2016) Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination. Frontiers in Immunology 7.
Crossref
Gabor Szebeni, Csaba Vizler, Lajos Nagy, Klara Kitajka & Laszlo Puskas. (2016) Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets. International Journal of Molecular Sciences 17:11, pages 1958.
Crossref
Athalia Rachel Pyzer, Leandra Cole, Jacalyn Rosenblatt & David E Avigan. (2016) Myeloid-derived suppressor cells as effectors of immune suppression in cancer. International Journal of Cancer 139:9, pages 1915-1926.
Crossref
Ronald J Fecek & Walter J Storkus. (2016) Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines. Immunotherapy 8:10, pages 1205-1218.
Crossref
Chloé Najac, Myriam M. Chaumeil, Gary Kohanbash, Caroline Guglielmetti, Jeremy W. Gordon, Hideho Okada & Sabrina M. Ronen. (2016) Detection of inflammatory cell function using 13C magnetic resonance spectroscopy of hyperpolarized [6-13C]-arginine. Scientific Reports 6:1.
Crossref
Zhenlong Ye, Zhong Li, Huajun Jin & Qijun Qian. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy 139 167 .
David Escors, James E. Talmadge, Karine Breckpot, Jo A. Van Ginderachter & Grazyna KochanKarine Breckpot. 2016. Myeloid-Derived Suppressor Cells and Cancer. Myeloid-Derived Suppressor Cells and Cancer 73 90 .
Angelica Loskog. (2015) Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles. Viruses 7:11, pages 5780-5791.
Crossref
Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle & Roberto Gasparini. 2015. 231 322 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.